Trust CO Of Vermont Johnson & Johnson Transaction History

Trust CO Of Vermont

$1.96 Billion
Q1 2025

A detailed history of Trust CO Of Vermont transactions in Johnson & Johnson stock. As of the latest transaction made, Trust CO Of Vermont holds 157,027 shares of JNJ stock, worth $24.5 Million. This represents 1.33% of its overall portfolio holdings.

Number of Shares

157,027

Previous 159,754 1.71%

Holding current value

$24.5 Million

Previous $23.1 Million 12.72%

% of portfolio

1.33%

Previous 1.15%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 24, 2025	SELL	$142.06 - $167.7 $387,397 - $457,317	-2,727 Reduced 1.71%	157,027 $26 Million
Q4 2024 Jan 15, 2025	SELL	$143.34 - $165.86 $71,670 - $82,930	-500 Reduced 0.31%	159,754 $23.1 Million
Q3 2024 Oct 16, 2024	BUY	$145.48 - $167.38 $52,372 - $60,256	360 Added 0.23%	160,254 $26 Million
Q2 2024 Jul 09, 2024	SELL	$144.38 - $157.78 $113,482 - $124,015	-786 Reduced 0.49%	159,894 $23.4 Million
Q1 2024 May 03, 2024	BUY	$155.22 - $162.74 $2.94 Million - $3.09 Million	18,971 Added 13.39%	160,680 $25.4 Million
Q4 2023 Mar 08, 2024	SELL	$145.6 - $158.88 $2.43 Million - $2.66 Million	-16,720 Reduced 10.55%	141,709 $22.2 Million
Q3 2023 Nov 27, 2023	BUY	$155.75 - $174.48 $392,490 - $439,689	2,520 Added 1.62%	158,429 $24.7 Million
Q2 2023 Jul 17, 2023	SELL	$154.35 - $166.11 $104,340 - $112,290	-676 Reduced 0.43%	155,909 $25.8 Million
Q1 2023 Apr 07, 2023	BUY	$151.05 - $180.26 $369,921 - $441,456	2,449 Added 1.59%	156,585 $24.3 Million
Q4 2022 Feb 09, 2023	BUY	$160.2 - $179.79 $929,159 - $1.04 Million	5,800 Added 3.91%	154,136 $27.2 Million
Q3 2022 Oct 24, 2022	BUY	$161.33 - $179.52 $342,987 - $381,659	2,126 Added 1.45%	148,336 $24.2 Million
Q2 2022 Jul 20, 2022	BUY	$168.19 - $186.01 $342,434 - $378,716	2,036 Added 1.41%	146,210 $26 Million
Q1 2022 Apr 05, 2022	SELL	$158.14 - $179.59 $306,159 - $347,686	-1,936 Reduced 1.33%	144,174 $25.6 Million
Q4 2021 Jan 21, 2022	SELL	$155.93 - $173.01 $185,868 - $206,227	-1,192 Reduced 0.81%	146,110 $25 Million
Q3 2021 Oct 22, 2021	BUY	$161.5 - $179.47 $79,942 - $88,837	495 Added 0.34%	147,302 $23.8 Million
Q2 2021 Jul 15, 2021	BUY	$159.48 - $171.07 $518,947 - $556,661	3,254 Added 2.27%	146,807 $24.2 Million
Q1 2021 Apr 16, 2021	SELL	$153.07 - $170.48 $115,108 - $128,200	-752 Reduced 0.52%	143,553 $23.6 Million
Q4 2020 Feb 03, 2021	BUY	$137.11 - $157.38 $237,611 - $272,739	1,733 Added 1.22%	144,305 $22.7 Million
Q3 2020 Nov 06, 2020	BUY	$140.38 - $153.83 $83,104 - $91,067	592 Added 0.42%	142,572 $21.2 Million
Q2 2020 Jul 17, 2020	SELL	$128.81 - $155.51 $4.38 Million - $5.29 Million	-34,014 Reduced 19.33%	141,980 $20 Million
Q1 2020 Apr 24, 2020	SELL	$111.14 - $153.99 $260,734 - $361,260	-2,346 Reduced 1.32%	175,994 $23.1 Million
Q4 2019 Feb 06, 2020	SELL	$127.5 - $146.44 $269,025 - $308,988	-2,110 Reduced 1.17%	178,340 $26 Million
Q3 2019 Oct 24, 2019	BUY	$126.95 - $142.14 $310,646 - $347,816	2,447 Added 1.37%	180,450 $23.3 Million
Q2 2019 Jul 26, 2019	BUY	$131.15 - $144.24 $112,133 - $123,325	855 Added 0.48%	178,003 $24.8 Million
Q1 2019 May 01, 2019	SELL	$125.72 - $139.79 $77,946 - $86,669	-620 Reduced 0.35%	177,148 $24.8 Million
Q4 2018 Jan 30, 2019	SELL	$122.84 - $147.84 $503,521 - $605,996	-4,099 Reduced 2.25%	177,768 $22.9 Million
Q3 2018 Oct 26, 2018	SELL	$121.58 - $142.88 $213,251 - $250,611	-1,754 Reduced 0.96%	181,867 $25.1 Million
Q2 2018 Jul 11, 2018	BUY	$119.4 - $131.76 $348,170 - $384,212	2,916 Added 1.61%	183,621 $22.3 Million
Q1 2018 May 18, 2018	SELL	$125.1 - $148.14 $306,119 - $362,498	-2,447 Reduced 1.34%	180,705 $23.2 Million
Q4 2017 Feb 02, 2018	SELL	$131.22 - $143.62 $671,977 - $735,478	-5,121 Reduced 2.72%	183,152 $25.6 Million
Q3 2017 Oct 24, 2017	BUY	$129.47 - $135.38 $24.4 Million - $25.5 Million	188,273	188,273 $24.5 Million

Others Institutions Holding JNJ

# of Institutions

4,602

Shares Held

1.71B

Call Options Held

16.9M

Put Options Held

14.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $409B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO Of Vermont, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO Of Vermont with notifications on news.

Account

Trust CO Of Vermont Johnson & Johnson Transaction History